Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Morgan Stanley Maintains Axsome Therapeutics (AXSM) Equal-Weight Recommendation
Fintel reports that on April 12, 2023, Morgan Stanley maintained coverage of Axsome Therapeutics (NASDAQ:AXSM) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 78.83% Upside
Morgan Stanley Maintains Mosaic (MOS) Equal-Weight Recommendation
Fintel reports that on April 12, 2023, Morgan Stanley maintained coverage of Mosaic (NYSE:MOS) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 19.99% Upside As
Goldman Sachs Maintains Sterling Check (STER) Buy Recommendation
Fintel reports that on April 12, 2023, Goldman Sachs maintained coverage of Sterling Check (NASDAQ:STER) with a Buy recommendation. Analyst Price Forecast Suggests 53.72% Upside
Truist Securities Maintains Coterra Energy Inc. (CTRA) Hold Recommendation
Fintel reports that on April 11, 2023, Truist Securities maintained coverage of Coterra Energy Inc. (NYSE:CTRA) with a Hold recommendation. Analyst Price Forecast Suggests 18.41%
Goldman Sachs Maintains Latham Group (SWIM) Sell Recommendation
Fintel reports that on April 11, 2023, Goldman Sachs maintained coverage of Latham Group (NASDAQ:SWIM) with a Sell recommendation. Analyst Price Forecast Suggests 96.76% Upside
Craig-Hallum Maintains Ebix (EBIX) Buy Recommendation
Fintel reports that on April 11, 2023, Craig-Hallum maintained coverage of Ebix (NASDAQ:EBIX) with a Buy recommendation. Analyst Price Forecast Suggests 67.51% Upside As of
B of A Securities Maintains Enphase Energy (ENPH) Neutral Recommendation
Fintel reports that on April 11, 2023, B of A Securities maintained coverage of Enphase Energy (NASDAQ:ENPH) with a Neutral recommendation. Analyst Price Forecast Suggests
Mizuho Maintains HCA Holdings (HCA) Buy Recommendation
Fintel reports that on April 11, 2023, Mizuho maintained coverage of HCA Holdings (NYSE:HCA) with a Buy recommendation. Analyst Price Forecast Suggests 5.82% Upside As
Susquehanna Maintains Forward Air (FWRD) Positive Recommendation
Fintel reports that on April 10, 2023, Susquehanna maintained coverage of Forward Air (NASDAQ:FWRD) with a Positive recommendation. Analyst Price Forecast Suggests 12.76% Upside As
Morgan Stanley Maintains Royalty Pharma (RPRX) Overweight Recommendation
Fintel reports that on April 10, 2023, Morgan Stanley maintained coverage of Royalty Pharma (NASDAQ:RPRX) with a Overweight recommendation. Analyst Price Forecast Suggests 48.83% Upside